Squeezed neatly between the North Atlantic Seafood Forum last week and the Boston Show now upon us, the past seven days have been filled to the brim with news.
It started with a bang with the game changing story over the weekend that the US Food and Drug Administration (FDA) is finally allowing genetically engineered salmon to be both grown and sold in the Unite States, opening the door specifically for AquaBounty to really start ramping up operations.
As soon as the news was announced, AquaBounty’s shares went on an explosive bull run, and analysts discussed how the company must now shift from development to commercialization.
